Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 7
1979 6
1980 2
1981 12
1982 13
1983 23
1984 18
1985 35
1986 44
1987 37
1988 41
1989 72
1990 61
1991 87
1992 73
1993 91
1994 84
1995 89
1996 119
1997 147
1998 202
1999 163
2000 254
2001 225
2002 318
2003 291
2004 310
2005 310
2006 350
2007 365
2008 373
2009 436
2010 463
2011 516
2012 498
2013 549
2014 575
2015 641
2016 661
2017 726
2018 708
2019 829
2020 1036
2021 1332
2022 1404
2023 1436
2024 309

Text availability

Article attribute

Article type

Publication date

Search Results

14,764 results

Results by year

Filters applied: . Clear all
Page 1
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.
Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A. Budd Haeberlein S, et al. J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30. J Prev Alzheimers Dis. 2022. PMID: 35542991 Clinical Trial.
Alzheimer's disease: Recent treatment strategies.
Vaz M, Silvestre S. Vaz M, et al. Eur J Pharmacol. 2020 Nov 15;887:173554. doi: 10.1016/j.ejphar.2020.173554. Epub 2020 Sep 15. Eur J Pharmacol. 2020. PMID: 32941929 Review.
Lecanemab: First Approval.
Hoy SM. Hoy SM. Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2. Drugs. 2023. PMID: 36856953 Review.
Combination Drug Therapy for the Management of Alzheimer's Disease.
Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, Ashraf GM, Mathew B, Bin-Jumah MN, Abdel-Daim MM. Kabir MT, et al. Int J Mol Sci. 2020 May 5;21(9):3272. doi: 10.3390/ijms21093272. Int J Mol Sci. 2020. PMID: 32380758 Free PMC article. Review.
Senolytic therapy for Alzheimer's disease.
Longo FM, Massa SM. Longo FM, et al. Nat Med. 2023 Oct;29(10):2409-2411. doi: 10.1038/s41591-023-02541-y. Nat Med. 2023. PMID: 37758897 No abstract available.
14,764 results
You have reached the last available page of results. Please see the User Guide for more information.